Tempus AI director David Epstein sells $25,922 in stock

Published 14/12/2024, 00:58
Tempus AI director David Epstein sells $25,922 in stock

David R. Epstein, a director at Tempus AI, Inc. (NASDAQ:TEM), recently sold 620 shares of the company's Class A Common Stock. The timing of this sale comes as the stock has experienced an 18.7% decline over the past week, according to InvestingPro data. The shares were sold at an average price of $41.81 each, totaling approximately $25,922. Following this transaction, Epstein holds 27,894 shares directly. This sale was executed under a Rule 10b5-1 trading plan, which was adopted on August 27, 2024. InvestingPro data shows analyst targets ranging from $50 to $74, with 2 analysts recently revising earnings estimates upward. Get access to more exclusive insider trading patterns and 6 additional ProTips with an InvestingPro subscription.

In other recent news, Tempus AI has been the focus of several key developments. The company's recent earnings report has led to a significant adjustment in its stock price target by Piper Sandler, increasing it from $40 to $70. Despite this positive adjustment, Piper Sandler maintains a neutral rating on the shares, indicating a cautious outlook on the company's future prospects.

Stifel, on the other hand, has downgraded Tempus AI stock from Buy to Hold, but increased the price target to $65. Needham has also raised its stock price target for Tempus AI to $56, maintaining its Buy rating.

In terms of acquisitions, Tempus AI's recent purchase of Ambry Genetics is seen as a strategic move that promises significant opportunities in data and applications over time. The company has also partnered with Avacta Therapeutics to utilize AI in advancing oncology drug development.

Additionally, Tempus AI's Tempus ECG-AF device, which uses artificial intelligence to identify patients at higher risk of atrial fibrillation/flutter, has recently received FDA clearance. These are the recent developments surrounding Tempus AI.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.